Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06418282 · ClinicalTrials.gov registry record · NA
Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
A NA study of Lymphedema and Chronic Venous Insufficiency, sponsored by Koya Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06418282 is a NA study of Lymphedema and Chronic Venous Insufficiency that is actively recruiting participants, run by Koya Medical. The registered enrollment target is 100 participants, below the 9,297-participant average among 34 other Lymphedema trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06418282, a NA study of Lymphedema and Chronic Venous Insufficiency, is actively recruiting participants, sponsored by Koya Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
An open-label, multi-center, prospective VA study to evaluate the effectiveness and health economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for lymphedema/phlebolymphedema
Conditions Studied
Interventions
- DEVICE Dayspring
Study Locations (1)
New York
- Glenn Jacobowitz - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-05-13 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06418282
The ClinicalTrials.gov registry entry for NCT06418282 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,297-participant average among 34 other Lymphedema trials with a reported enrollment target (99% lower). The listed sponsor is Koya Medical, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Lymphedema appearing as the primary indexed condition, and to 1 intervention - of which Dayspring is the first listed.
NCT06418282 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06418282 about?
NCT06418282 is a clinical study titled "Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema". An open-label, multi-center, prospective VA study to evaluate the effectiveness and health economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for lymphedema/phlebolymphedema
What is the current status of trial NCT06418282?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-05-13. Estimated completion is 2026-01-31.
What conditions does trial NCT06418282 study?
This clinical trial studies the following conditions: Lymphedema, Chronic Venous Insufficiency, Phlebolymphedema.
What interventions are being tested in trial NCT06418282?
The interventions under investigation include: Dayspring (DEVICE).
Who is sponsoring clinical trial NCT06418282?
This trial is sponsored by Koya Medical, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06418282 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
RECRUITING · NA
-
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
RECRUITING · NA
-
Pedal Pump and Leg Lymphedema
RECRUITING · NA
-
Comparing Two Ways to Manage Head and Neck Lymphedema
RECRUITING · NA
-
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
RECRUITING · NA
-
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.